Last reviewed · How we verify

chapped or cracked skin — Treatment Landscape & Competitive Intelligence

chapped or cracked skin (disease) competitive landscape: 2 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

2 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating chapped or cracked skin, deduplicated by molecule. See the full disease page for line-of-therapy detail.

DrugGenericSponsorClassTargetLine of therapyFirst approval
DermacinRx Surgical ComboPak COMBO PureTek Corporation
First Aid 4pc MIni Stick Kit MYRRH Spry Life LLC

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

  1. PureTek Corporation · 1 drug in chapped or cracked skin
  2. Spry Life LLC · 1 drug in chapped or cracked skin

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in chapped or cracked skin:

Cite this brief

Drug Landscape (2026). chapped or cracked skin — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/chapped-or-cracked-skin. Accessed 2026-06-10.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing